Logos Global Management LP Unicycive Therapeutics, Inc. Transaction History
Logos Global Management LP
- $1.07 Billion
- Q2 2024
A detailed history of Logos Global Management LP transactions in Unicycive Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 3,469,927 shares of UNCY stock, worth $1.56 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
3,469,927
Previous 3,469,927
-0.0%
Holding current value
$1.56 Million
Previous $1.73 Million
-0.0%
% of portfolio
0.16%
Previous 0.16%
Shares
1 transactions
Others Institutions Holding UNCY
# of Institutions
26Shares Held
17MCall Options Held
0Put Options Held
0-
Vivo Capital, LLC Palo Alto, CA3.47MShares$1.56 Million0.26% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.82MShares$1.27 Million0.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.63MShares$1.18 Million0.02% of portfolio
-
Bvf Inc San Francisco, CA2.2MShares$990,0000.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.14MShares$512,1990.0% of portfolio
About Unicycive Therapeutics, Inc.
- Ticker UNCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,052,500
- Market Cap $6.77M
- Description
- Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Al...